These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30609381)

  • 1. Particle engineering at the drug substance, drug product interface: a comprehensive platform approach to enabling continuous drug substance to drug product processing with differentiated material properties.
    Schenck L; Koynov A; Cote A
    Drug Dev Ind Pharm; 2019 Apr; 45(4):521-531. PubMed ID: 30609381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
    Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
    Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Co-Processed API Approach for a Shear Sensitive Compound Affording Improved Chemical Stability and Streamlined Drug Product Processing.
    Schenck L; Neri C; Jia X; Schafer W; Axnanda S; Canfield N; Li F; Shah V
    J Pharm Sci; 2021 Sep; 110(9):3238-3245. PubMed ID: 34089710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal and Particle Engineering Strategies for Improving Powder Compression and Flow Properties to Enable Continuous Tablet Manufacturing by Direct Compression.
    Chattoraj S; Sun CC
    J Pharm Sci; 2018 Apr; 107(4):968-974. PubMed ID: 29247737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
    Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Feeding and Blending Demonstration with Co-Processed Drug Substance.
    Erdemir D; Gawel J; Yohannes B; Yates P; Tang D; Ha K; Breza B; DiMaso E; Abebe A; Zombek J
    J Pharm Sci; 2023 Aug; 112(8):2046-2056. PubMed ID: 36462708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic Particle Engineering of Hydrophobic Drug with Eudragit E100─Bridging the Amorphous and Crystalline Gap.
    Shikha S; Lee YW; Doyle PS; Khan SA
    Mol Pharm; 2022 Nov; 19(11):4345-4356. PubMed ID: 36268657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L; Mann AKP; Liu Z; Milewski M; Zhang S; Ren J; Dewitt K; Hermans A; Cote A
    Int J Pharm; 2019 Mar; 559():147-155. PubMed ID: 30654058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Commentary on Co-Processed API as a Promising Approach to Improve Sustainability for the Pharmaceutical Industry.
    Schenck L; Risteen B; Johnson LM; Koynov A; Bonaga L; Orr R; Hancock B
    J Pharm Sci; 2024 Feb; 113(2):306-313. PubMed ID: 38065243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Drug-Excipient Particle Attributes with Droplet Microfluidic-based Extractive Solidification Enables Improved Powder Rheology.
    Ng DZL; Nelson AZ; Ward G; Lai D; Doyle PS; Khan SA
    Pharm Res; 2022 Feb; 39(2):411-421. PubMed ID: 35119593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach.
    Bohr A; Boetker JP; Rades T; Rantanen J; Yang M
    Curr Pharm Des; 2014; 20(3):325-48. PubMed ID: 23651398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
    Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
    Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight Into a Novel Strategy for the Design of Tablet Formulations Intended for Direct Compression.
    Capece M; Huang Z; Davé R
    J Pharm Sci; 2017 Jun; 106(6):1608-1617. PubMed ID: 28283431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical excipients properties and screw feeder performance in continuous processing lines: a Quality by Design (QbD) approach.
    Santos B; Carmo F; Schlindwein W; Muirhead G; Rodrigues C; Cabral L; Westrup J; Pitt K
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2089-2097. PubMed ID: 30113219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance.
    Hancock BC; Carlson GT; Ladipo DD; Langdon BA; Mullarney MP
    Int J Pharm; 2002 Jul; 241(1):73-85. PubMed ID: 12086723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needles to Spheres: Evaluation of inkjet printing as a particle shape enhancement tool.
    Zettl M; Winter C; Mantanus J; Hadjittofis E; Rome S; Leitinger G; Hsiao WK; Roblegg E; Pinto JT; Spoerk M
    Eur J Pharm Biopharm; 2023 Mar; 184():92-102. PubMed ID: 36707008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering.
    Wang C; Hu S; Sun CC
    Mol Pharm; 2017 Oct; 14(10):3399-3408. PubMed ID: 28825961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.